Feugiat pretium nibh ipsum consequat nisl velavida trum quisque non tellus orci rudor ellus mauris a diam maecenas arcu.

Tel: +(123) 456 7890


620 Eighth Avenue, New York

Denial Management

Collect More!

90% of denials are preventable and 60% are recoverable

According to MGMA 65% of claim denials were never corrected

73% of All Medicare appeals will be overturned in the appeal process

Med-Bill, Inc. will help your practice recover more cash from your denials and improve future revenue recovery. Our expertise in denial management helps your organization increase denial recovery and workflow efficiency, resulting in a significant impact on your bottom line.

Med-Bill, Inc. excels in the A/R follow up services and offers end-to-end healthcare support. Our recovery process will be used to accelerate the re-submission of your denied claims and streamline your A/R. It is our goal to help you obtain complete and prompt reimbursement from all your payers.

What does a 20% or even a 10% improvement in your denial management mean to your bottom line?

Our Services Include:

Med-Bill Favicon

Improving Denial Management Workflow

Med-Bill Favicon

Identifying and Correcting Root Causes of Denials to improve clean claim rate

Med-Bill Favicon

Streamline workflows for greater productivity, faster appeals, and improved cash cycle

Med-Bill Favicon

Denial Prevention & Training

The Most Common Reasons for Claim Denials

Each health organization is different, and the causes for claim denials will vary depending on the situation. Here are the top reasons:

  • Invalid subscriber information: This can be due to expired policy information or errors introduced by manual entry of patient names or ID numbers.
  • Non-covered services: The list of allowed services associated with each specific diagnosis by each insurance company are in a state of near-constant flux.
  • Coding errors: These include improper use of modifiers or inaccurate reporting of bundled services.
  • Timing errors: Failure to submit claims in a timely manner, or to obtain pre-authorization.
  • Pre-existing conditions: These are any conditions present before the policy was purchased.

Our approach for A/R Follow-up:

  • Auditing claims to reduce the aging/claims rejection. Our audit process is linked to the principles of a continuous quality check at every level.
  • Rectifying errors by billing the claims in a timely manner: Our proficient team understands the criteria of the mistakes.
  • Stringent payer follow-up: We run various reports by the payer and by patients to determine the outstanding amount, and then address the issues proactively. Follow-up is carried out aggressively by calling to gain denial issues and determining a resolution.

Let’s help you collect more

Anthony Zografos, PhD

Founder and CEO

Anthony founded SafeTraces, Inc. in 2013 and is the co-inventor of the company's technology. Anthony has held executive positions at a number of Fortune 500 companies and several start-ups with three successful exits. He holds a Ph.D. in Mechanical Engineering from the University of Massachusetts, an M.B.A. from the Haas School of Business at the University of California, Berkeley, and a B.S. in Mechanical Engineering from the National Technical University in Athens, Greece.

Ulrike Hodges, PhD

VP, Business Operations

Ulrike is a founding member of SafeTraces and responsible for business operations, go-to-market and marketing strategy. Ulrike spent over 10 years in the private equity environment, holding executive management positions in several early and mid-stage technology companies. Ulrike holds a Ph.D. in Political Science from the University of California, Berkeley, and an M.A. in International Studies from the University of Washington, Seattle.

Brandon Martin

VP of Sales, Safety Assurance

Brandon became part of SafeTraces in December 2018 and leads sales of both safety assurances solutions, saniDART and goDART. Brandon has a strong entrepreneurial, business development and sales and marketing background, with over 15 years of experience building teams, developing strategic partnerships, and driving revenue growth. Brandon has co-founded four companies since 2005.

Dan Reighn

VP of Sales, Source Assurance

Dan joined SafeTraces in January 2019 and heads up sales of the source assurance solution, miniDART. Dan has over 12 years of experience selling traceability and other supply chain solutions, as well as SaaS and cloud software solutions to growers and processors in agricultural sectors, including fresh produce and seeds. Dan graduated from the University of California, Berkeley.

Damon Cole, MSME

VP, Platform Development

Damon joined SafeTraces in August 2018 and heads up the engineering group that develops all of SafeTraces platform technology. Damon has successfully brought 14 major new leading-edge products to market in the high technology arena, managing major develop programs at Fortune 500 companies including joint ventures and international collaborative projects. He holds a B. S. in Mechanical Engineering at LeTourneau University and completed his graduate work at San Jose State University.

Phil Arnold, MBA

VP, Manufacturing

Phil is responsible for manufacturing and supply chain operations. He has deep experience in multidisciplinary, distributed technology development and management. Phil previously held executive positions at Endless and Finesse Solutions and launched several award-winning technology products. Phil holds a M.B.A. from Golden Gate University in San Francisco and a B.S. in Materials Engineering from Rensselaer Polytechnic Institute in Troy, NY.

Erik Malmstrom, MBA

Director, Business Development

Erik joined the SafeTraces team in January 2018 and is responsible for driving the company's commercial strategy, developing new customer markets, and establishing strategic partnerships. Previously, he served in management positions in food and ag tech, and international trade and development at Cargill, Farmers Business Network, and the White House. He received a B.A. from the University of Pennsylvania and a joint M.B.A. and M.P.P. from Harvard Business and Kennedy Schools, and was a Rotary Ambassadorial Scholar at Makerere University in Uganda.

Quin Chou, MS

Manager, Research and Development

Quin Chou became part of SafeTraces in May 2018 and serves as its R&D Manager, responsible for managing the assay development team and advancing cutting-edge research. Quin brings 30 years of experience in biotech/ pharma, R&D, operations, sales and management. He holds several patents and has published widely. He started his career as part of the Nobel-prize winning at Cetus, where PCR technology was invented. Quin holds a M. S. in Microbiology from the University of California, Berkeley.